Inorganic Arsenic and Human Prostate Cancer
Author Information
Author(s): Benbrahim-Tallaa Lamia, Waalkes Michael P.
Primary Institution: National Cancer Institute at the National Institute of Environmental Health Sciences
Hypothesis
We critically evaluated the etiologic role of inorganic arsenic in human prostate cancer.
Conclusion
Available evidence in human populations and human cells in vitro indicates that the prostate is a target for inorganic arsenic carcinogenesis.
Supporting Evidence
- Multiple studies in humans reveal an association between environmental inorganic arsenic exposure and prostate cancer mortality or incidence.
- Many human studies provide clear evidence of a dose–response relationship.
- Arsenic exposure is linked to increased mortality from prostate cancer in areas with high arsenic levels in drinking water.
Takeaway
Arsenic, a common contaminant in drinking water, may cause prostate cancer in humans, especially in areas with high exposure.
Methodology
The study assessed data from epidemiologic studies and in vitro models regarding arsenic exposure and prostate cancer.
Potential Biases
Potential ecological fallacy in interpreting village-level data as individual-level risk.
Limitations
The study lacks whole animal models specifically showing prostate cancer as a target for arsenic.
Participant Demographics
The studies primarily involved populations from Taiwan and the U.S. with varying levels of arsenic exposure.
Statistical Information
Confidence Interval
95% CI, 1.4–2.6
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website